Skip to main content
CME logo

CME · Cme Group Inc.

Track CME — free
Market Cap
$103.32B
Shares
359.58M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$6.52B +6.4%
FY2025 Revenue FY2007–FY2025
Net Income
$4.07B +15.5%
FY2025 Net Income FY2007–FY2025
Operating Margin
64.86% +0.7pp
FY2025 Operating Margin FY2007–FY2025
Diluted EPS
$11.16 +15.4%
FY2025 Diluted EPS FY2007–FY2025
Operating Cash Flow
$4.28B +15.9%
FY2025 Operating Cash Flow FY2007–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008 FY2007
$6.77B $6.52B $6.13B $5.58B $5.02B $4.69B $4.88B $4.87B $4.31B $3.64B $3.6B $3.33B $3.11B $2.94B $2.91B $3.28B $3B $2.61B $2.56B $1.76B
$224.2M $223.4M $221.7M $226.6M $227.7M $237.6M $311.2M $314.7M $130M $95.5M $96.1M $99.4M $100.6M $103M $116.2M $132M $128.1M $125.1M $98.7M $33.9M
$107.5M $115.1M $126M $134.9M $147.8M $153.2M $158.6M $118.7M $113M $129.2M $129.2M $132.6M $135.1M $136.9M $128.5M $129.9M $126.3M $137.3M $105.7M
-$600K $5.3M $4.8M $8.9M
$27.1M
$2.36B $2.29B $2.2B $2.14B $2B $2.04B $2.25B $2.28B $1.7B $1.33B $1.39B $1.34B $1.34B $1.3B $1.22B $1.26B $1.17B $1.02B $978.8M $704.2M
$4.41B $4.23B $3.93B $3.44B $3.02B $2.65B $2.64B $2.59B $2.61B $2.31B $2.2B $1.99B $1.77B $1.64B $1.69B $2.02B $1.83B $1.59B $1.58B $1.05B
64.86% 64.13% 61.58% 60.08% 56.4% 54.01% 53.16% 60.51% 63.4% 61.21% 59.78% 56.82% 55.75% 58.05% 61.61% 60.96% 60.82% 61.78% 59.9%
$4.34B $4.05B $3.56B $3.15B $2.79B $2.79B $2.75B $2.73B $2.42B $2.33B $2.12B $1.9B $1.77B $1.83B $2.15B $1.96B $1.72B $1.72B $1.16B
$1.19B $1.1B $609.9M $717.9M $474.4M $728.4M $84.7M $101.8M $170.2M $215.7M $87.1M -$31.9M $3M -$36M $1.4M -$84.6M -$109.2M -$151.6M -$334.2M $43.9M
$30.4M
$384.6M $371.7M $350.9M $296.9M $301.1M $245.8M $190.6M $176.8M $152.8M $129.2M $110.2M $100M $84.8M $70.5M $30.7M -$4.3M -$6.4M -$6.8M $31.5M -$14M
$331.1M $352.8M $3.6M $72.1M $4.8M $117M -$5.5M -$1.8M $97.4M $88.8M $0
$5.59B $5.33B $4.54B $4.15B $3.49B $3.37B $2.72B $2.69B $2.78B $2.53B $2.29B $1.96B $1.77B $1.6B $1.69B $1.94B $1.72B $1.44B $1.25B
$1.31B $1.26B $1.02B $927.4M $799.3M $736.7M $615.7M $573.8M $814.1M -$1.54B $753.5M $709.8M $644.5M $622.9M $786.7M $122.1M $769.8M $611.7M $532.5M $437.3M
$4.29B $4.07B $3.53B $3.23B $2.69B $2.64B $2.11B $2.12B $1.96B $4.06B $1.53B $1.25B $1.13B $976.8M $896.3M $1.81B $951.4M $825.8M $715.5M $658.5M
62.45% 57.52% 57.83% 53.61% 56.23% 43.12% 43.48% 45.53% 111.49% 42.67% 37.48% 36.21% 33.27% 30.75% 55.24% 31.67% 31.61% 27.94% 37.5%
$0 $0 $500K $1.2M -$700K $1.5M $0 $0 -$200K $1.3M $10.4M $2.1M $700K $0
$4.27B $4.02B $3.48B $3.19B $2.66B $2.62B $2.11B $2.12B
$4.26B $3.48B $3.3B $2.5B $2.56B $2.24B $2.11B $1.95B $4.09B $1.6B $1.16B $981.3M $919.5M $994M $2.03B $973.5M $859.9M $558.3M $658.4M
USD/shares $11.88 $11.18 $9.69 $8.87 $7.41 $7.30 $5.88 $5.93 $5.73 $12.00 $4.55 $3.71 $3.37 $2.94 $2.71 $5.45 $2.87 $12.44 $12.18 $15.05
USD/shares $11.79 $11.16 $9.67 $8.86 $7.40 $7.29 $5.87 $5.91 $5.71 $11.94 $4.53 $3.69 $3.35 $2.92 $2.70 $5.43 $2.86 $12.41 $12.13 $14.93
shares 359.65M 359.39M 359.02M 358.71M 358.34M 357.76M 357.16M 342.34M 338.71M 337.5M 336.22M 334.41M 332.68M 331.25M 332.74M 331.49M 66.37M 58.74M 43.75M
shares 360.31M 359.94M 359.5M 359.18M 358.93M 358.52M 358.24M 343.74M 340.23M 338.97M 337.89M 336.06M 334.4M 332.32M 333.81M 332.48M 66.55M 58.97M 44.11M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $2B in buybacks, $31.73B in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Peer median 7.15×
EV/EBIT
Peer median 24.60×
P/E (TTM)
24.37×
Peer median 26.08×

Peer medians compare against the 9 similar-size Financial Data & Stock Exchanges companies (of 14 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Clearing and Transaction Fees $5,281,100,000 $4,988,200,000 $4,588,500,000 $4,142,700,000 $3,765,100,000 $3,897,400,000 $3,946,100,000 $3,667,000,000
Market Data $803,100,000 $710,200,000 $663,700,000 $610,900,000 $576,900,000 $545,400,000 $518,500,000 $449,600,000
Other Revenue $436,400,000 $431,700,000 $326,700,000 $265,800,000 $347,700,000 $440,800,000 $403,400,000 $192,800,000
Key facts CIK 1156375 CUSIP 12572Q105 13F (30d) 1080 filings 1037 filers Visit website Investor relations